SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting highly positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, showcasing strong efficacy and potential disease-modifying effects. This, combined with a robust financial position and an eagerly awaited Investor Day, is fueling community discussion around significant undervaluation, a potential short squeeze, and best-in-class potential for its nanobody platform.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ trends as the market grapples with the fallout from the Supreme Court's tariff ruling and the subsequent 15% global tariffs, fueling community debate on economic uncertainty and the tech index's consistent resilience ahead of Nvidia's pivotal earnings.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for Bysanti, a new treatment for bipolar I disorder and schizophrenia, which was granted New Chemical Entity (NCE) status with patent protection extending to 2044. The community is actively discussing this as a major re-rating catalyst, anticipating significant institutional buying, and speculating on the drug's blockbuster potential alongside future pipeline developments.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid renewed uncertainty surrounding global trade policy, driven by recent tariff decisions that have sparked market volatility. The community is sharply divided, with bears anticipating a major downturn following weekend declines, while bulls expect a typical 'V-shape' recovery, particularly ahead of key tech earnings this week.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

The recent acquisition of Astria Therapeutics, integrating the late-stage HAE drug navenibart, is driving BioCryst's conversation, especially with new data presentations for navenibart and Orladeyo expected at a medical conference and upcoming earnings. The community is actively discussing the potential of these pipeline advancements against persistent concerns about the stock's valuation and significant short interest.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending after receiving a prestigious Lightwave Award for its Teralight 1.6T product, intensifying community speculation for imminent major customer orders or partnerships in AI data center optical interconnects, even as some investors express frustration over management's continued silence and past capital raises.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to a dual financing announcement, including a non-dilutive royalty deal for its prostate cancer candidate and a concurrent public offering, which has sparked intense community debate over dilution and management's long-term commercialization strategy. Bulls view the capital raise as crucial validation and runway for its promising oncology pipeline, while bears express strong concerns about shareholder value and the impact on a potential "go it alone" approach.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF is trending with active debate around the Supreme Court's impending tariff ruling, as investors weigh the potential for a small-cap breakout if trade barriers ease against risks of new tariffs or wider market volatility. This uncertainty is fueling diverse technical outlooks and notable options hedging, highlighting its role as a key sentiment indicator.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohen's recent cryptic social media posts are driving intense speculation among investors about an imminent, monumental acquisition or strategic move, leveraging GameStop's substantial cash reserves. This dynamic fuels a fierce debate between ardent holders anticipating a massive short squeeze and skeptics citing ongoing price suppression and the absence of concrete company details.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to the expanding deployment of its driverless robotaxi services with Uber across the Middle East and the successful market entry of its WePilot ADAS system with major automotive OEMs, generating significant revenue growth and improved margins in its latest earnings report. The community actively discusses the stock's perceived undervaluation compared to its global operational achievements and increasing institutional backing, offset by a desire for more explicit near-term financial guidance from management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Granite Investment Partners LLC Lowers Stock Position in NAPCO Security Technologies, Inc. $NSSC

Granite Investment Partners LLC trimmed its position in shares of NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) by 14.2% in the third quarter, according to the company in its most...

NAPCO Security Technologies, Inc. (NASDAQ:NSSC) Receives Consensus Rating of "Moderate Buy" from Brokerages

NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Get Free Report) has received an average rating of "Moderate Buy" from the eight ratings firms that are presently covering the company, MarketBeat.com...

CenterBook Partners LP Sells 142,827 Shares of NAPCO Security Technologies, Inc. $NSSC

CenterBook Partners LP cut its holdings in shares of NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) by 52.3% during the third quarter, according to its most recent 13F filing with the...

First National Bank of Omaha Purchases Shares of 82,549 NAPCO Security Technologies, Inc. $NSSC

First National Bank of Omaha acquired a new position in shares of NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) during the third quarter, according to the company in its most recent...

NAPCO Security Technologies, Inc. $NSSC Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. boosted its position in NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) by 100.0% during the 3rd quarter, according to the company in its most recent...

Envestnet Asset Management Inc. Sells 221,251 Shares of NAPCO Security Technologies, Inc. $NSSC

Envestnet Asset Management Inc. lowered its stake in shares of NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) by 34.4% during the 3rd quarter, according to the company in its most...

50,999 Shares in NAPCO Security Technologies, Inc. $NSSC Purchased by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans acquired a new stake in shares of NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Free Report) during the 3rd quarter, according to its most recent Form 13F filing...

Insider Selling: NAPCO Security Technologies (NASDAQ:NSSC) CEO Sells 150,000 Shares of Stock

NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Get Free Report) CEO Richard Soloway sold 150,000 shares of the company's stock in a transaction dated Thursday, February 5th. The shares were sold at...

NAPCO Security Technologies (NASDAQ:NSSC) CEO Sells $6,411,000.00 in Stock

NAPCO Security Technologies, Inc. (NASDAQ:NSSC - Get Free Report) CEO Richard Soloway sold 150,000 shares of the firm's stock in a transaction dated Thursday, February 5th. The shares were sold at an...

Is Napco (NSSC) a Solid Growth Stock? 3 Reasons to Think "Yes"

Napco (NSSC) possesses solid growth attributes, which could help it handily outperform the market.

Napco Security Technologies, Inc. engages in the development, manufacture, and distribution of security products. Its products and services include access control, video, fire, communications, and commercial applications. It offers intrusion and fire alarm systems, access control, and door locking systems. It focuses on NAPCO Security Systems, Alarm Lock, Marks USA Custom Locking, and Napco Access Pro divisions. The company was founded in 1969 and is headquartered in Amityville, NY.

Current Price	$45.86
Prev Close	$44.98
Open	$44.81
Dividend Yield	1.73%
50-Day Moving Average	$41.64
Beta	1.22
Avg. Volume	347,805.25
PE Ratio	34.75

52-Week High	$48.12
52-Week Low	$19.00
Market Capitalization	$1.77B
EPS (Annual)	$1.19
Price to Book	8.85
Revenue Per Employee	$171,179.08

NSSC
NAPCO Security Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NSSC News

NSSCNAPCO Security Technologies Inc